NCT05723653 · University of Chicago
Hybrid Type I Effectiveness-Implementation Trial of a Social Network Support Intervention
What this study is about
The goal of this Hybrid Type I effectiveness-implementation trial is to test an evidence-based, flexible, and tailored intervention that leverages existing social network members to promote retention in care and viral suppression among people living with HIV aged 18-49.
View original scientific description
The goal of this Hybrid Type I effectiveness-implementation trial is to test an evidence-based, flexible, and tailored intervention that leverages existing social network members to promote retention in care and viral suppression among people living with HIV aged 18-49.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- for Index Participants:
- Aged 18-49 years old, inclusive
- Speak English
- Own a cell phone not shared with anyone else
- Have missed at least one HIV care scheduled visit or have not been virally suppressed in the past 24 months.
- Resides in Chicagoland, Illinois or Alabama
Exclusion criteria
- for Index Men:
- If a participant fails to meet all inclusion criteria Inclusion Criteria for Support Confidants:
- Index agrees to engage the Support Confidant
- Age 18 years or older
- Speaks English
- Owns a cell phone not shared with others
- Is not a romantic/sexual partner of the Index participant Exclusion Criteria:
- Romantic/Sexual partners of Index participant
- Relationship strain or abuse present in Index-Support Confidant relationship
Where
- Birmingham, Alabama
- Huntsville, Alabama
- Chicago, Illinois
- New Orleans, Louisiana
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Apr 8, 2026 · Source of record for eligibility and locations